Gawrieh S, Noureddin M, Loo N, Mohseni R, et al. Saroglitazar, a PPAR-alpha/gamma Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial. Hepatology 2021;74:1809-1824.
PMID: 33811367